Table TDI-19. New and all clients entering outpatient treatment: distribution by primary drug at treatment in 2004 for those countries supplying data – Part (ii) All clients

Country

Opioids

Cocaine

Stimulants

Hypnotics, sedatives

Hallucinogens

Volatile inhalants

Cannabis

Other substances

Base
(known status)

Status unknown

Czech Republic

35.6

0.1

39.8

1.2

0.4

2.5

19.9

0.4

2141

6

Denmark

38.1

5.7

9.8

2.1

0.0

0.0

32.6

11.7

2776

1135

Germany

52.3

5.9

6.0

2.5

0.2

0.1

30.2

2.8

44448

0

Greece

85.2

2.8

0.5

0.8

0.2

0.1

10.4

0.1

2371

0

Italy

73.4

9.2

0.9

0.4

0.1

0.2

13.2

2.6

132103

3463

Cyprus

61.9

8.1

1.7

0.0

0.4

0.0

28.0

0.0

236

1

Hungary

16.3

0.7

9.6

12.2

0.5

0.8

45.3

14.7

9532

26

Malta

83.5

5.8

3.0

0.2

0.0

0.0

7.4

0.2

623

43

Netherlands

29.4

36.6

5.5

2.0

0.8

0.1

24.9

0.8

9887

0

Slovenia

84.9

1.3

0.7

0.4

0.0

0.0

12.7

0.0

1113

0

Slovakia

31.0

0.8

25.2

11.6

0.7

14.6

15.1

1.1

735

0

Finland

38.1

0.1

31.4

3.0

0.1

0.3

26.4

0.6

1419

0

Sweden

29.8

2.4

28.2

9.2

0.1

0.2

28.1

2.0

2198

0

United Kingdom

70.5

9.5

5.0

2.1

0.1

0.4

11.3

1.2

84737

6741

Bulgaria

95.7

0.1

0.6

0.2

0.0

0.1

3.2

0.0

1435

0

 

 

 

 

 

 

 

 

 

 

 

Total

65.1

9.1

4.0

1.8

0.1

0.3

16.9

2.6

295754

11415

Notes:

See 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2005 Reitox national reports - TDI outpatient treatment centres

Data filter | tditab19b-en.xml